Pharma emerges well from WHO neglected tropical disease report
This article was originally published in Scrip
While rising supplies of quality-assured, cost-effective medicines have contributed to "unprecedented progress" against 17 neglected tropical diseases (NTDs) over the past few years, the World Health Organization (WHO) says the provision of such drugs - along with other measures - needs to be stepped up.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.